The bioinformatic person is doing all that. She trimmed the adapters and tried aligning the reads to the genome using tophat. She got 40% alignment there. We tried blasting some of the unaligned reads and realized that something went wrong with the tophat run as some of them were aligning to chromosome M, chr 1, 4 etc. She will be doing the alignment again with STAR this time but to save on time she also ran the RSEM along side and got these low percentage alignments to transcriptome so I wanted to know if we are missing out on anything?
-
-
It would be helpful if you posted some basic quality metrics, such as you get from FastQC. There's not enough information to determine what the problem is or even if there is a problem.Comment
-
Ok. I have looked at the FastQC report of the samples and it looks fine to me. What kind of information should I give from FastQC report?Comment
-
The whole thing as PDF is good way to start. But particularly the quality histograms, anything that failed the tests, and anything related to mapping. And the stats from adapter trimming, the command lines you used for each program, the top hits and mapping rate you got from Blast... etc.Comment
-
I will have to ask my bioinformatician for the stats after adapter trimming. I will get back on this. Thanks for your time.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment